Skip to content

Economic Burden of NAFLD

The Economic Burden of Non-Alcoholic Fatty Liver Disease Patients in Flanders, Belgium

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05035043
Enrollment
73
Registered
2021-09-05
Start date
2021-03-01
Completion date
2024-04-30
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NAFLD, Non-Alcoholic Fatty Liver Disease

Brief summary

To determine the economic burden of NAFLD (Non-Alcoholic-Fatty-Liver Disease) patients in Belgium, Flanders by means of a bottom-up approach.

Interventions

OTHERDetermination of the economic burden NAFLD patients

Determination of the economic burden NAFLD patients (Healthcare costs, patient costs, burden of disease

Sponsors

Hasselt University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* having NAFLD as was diagnosed by FibroScan®, * 18 years or older * BMI ≥ 25 kg/m²

Exclusion criteria

* unable to give informed consent * \>70 years

Design outcomes

Primary

MeasureTime frameDescription
iMTA MCQbaselineHealthcare cost measured with the iMTA MCQ (Institute for Medical Technology Assessment Medical Consumption Questionnaire). The volumes of used healthcare costs were multiplied with the unit costs of these corresponding services.

Secondary

MeasureTime frameDescription
iMTA MCQBaselinePatient cost measured with the iMTA MCQ (Institute for Medical Technology Assessment Medical Consumption Questionnaire). The volumes of used healthcare costs were multiplied with the unit costs of these corresponding services.
EuroQol-5D-5Lbaseline: Health related quality of life questionnaire EuroQol-5D-5L is used. Five levels are score in 5 dimensions. It is scaled from 0 to 100%. A higher score indicates a higher quality of life.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026